| A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. | |
| | |
MedLine Citation:
|
PMID: 20688887 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND OBJECTIVES: Studies of the impact of systemic lupus erythematosus (SLE) and its pregnancy complications have yielded conflicting results. Major limitations of these studies relate to their small numbers of patients and retrospective designs. The aim of this study was to perform a systematic literature review of pregnancy outcomes in women with SLE and a meta-analysis of the association of lupus nephritis with adverse pregnancy outcomes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We searched electronic databases from 1980 to 2009 and reviewed papers with validity criteria. Random-effects analytical methods were used to evaluate pregnancy complications rates. RESULTS: Thirty-seven studies with 1842 patients and 2751 pregnancies were included. Maternal complications included lupus flare (25.6%), hypertension (16.3%), nephritis (16.1%), pre-eclampsia (7.6%), and eclampsia (0.8%). The induced abortion rate was 5.9%, and when excluded, fetal complications included spontaneous abortion (16.0%), stillbirth (3.6%), neonatal deaths (2.5%), and intrauterine growth retardation (12.7%). The unsuccessful pregnancy rate was 23.4%, and the premature birth rate was 39.4%. Meta-regression analysis showed statistically significant positive associations between premature birth rate and active nephritis and increased hypertension rates in subjects with active nephritis or a history of nephritis. History of nephritis was also associated with pre-eclampsia. Anti-phospholipid antibodies were associated with hypertension, premature birth, and an increased rate of induced abortion. CONCLUSIONS: In patients with SLE, both lupus nephritis and anti-phospholipid antibodies increase the risks for maternal hypertension and premature births. The presented evidence further supports timing of pregnancy relative to SLE activity and multispecialty care of these patients. |
| | |
Authors:
|
Andrew Smyth; Guilherme H M Oliveira; Brian D Lahr; Kent R Bailey; Suzanne M Norby; Vesna D Garovic |
Related Documents
:
|
20203157 - Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene ... 15593367 - Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. 16735457 - Impaired expression of endometrial differentiation markers and complement regulatory pr... 19584727 - Prevention of complete heart block in children of mothers with anti-ssa/ro and anti-ssb... 2599507 - Ultrasound-guided transfundal uterine sperm recovery from macaca fascicularis. 17885457 - Bariatric surgery and adolescent gynecology. |
Publication Detail:
|
Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Review Date: 2010-08-05 |
Journal Detail:
|
Title: Clinical journal of the American Society of Nephrology : CJASN Volume: 5 ISSN: 1555-905X ISO Abbreviation: Clin J Am Soc Nephrol Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-11-08 Completed Date: 2011-02-18 Revised Date: 2011-11-01 |
Medline Journal Info:
|
Nlm Unique ID: 101271570 Medline TA: Clin J Am Soc Nephrol Country: United States |
Other Details:
|
Languages: eng Pagination: 2060-8 Citation Subset: IM |
Affiliation:
|
Department of Medicine, National University of Ireland, Galway, Ireland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortion, Induced Abortion, Spontaneous / etiology Antibodies, Antiphospholipid / blood Female Fetal Death / etiology Fetal Growth Retardation / etiology Humans Hypertension, Pregnancy-Induced / etiology Live Birth Lupus Erythematosus, Systemic / blood, complications* Lupus Nephritis / blood, complications* Pregnancy Pregnancy Complications / blood, etiology* Pregnancy Outcome* Premature Birth / etiology Risk Assessment Risk Factors Stillbirth |
| Grant Support | |
ID/Acronym/Agency:
|
K08HD051714/HD/NICHD NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Antiphospholipid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.
Next Document: Phylogeography of the Marine Otter (Lontra felina): historical and contemporary factors determining ...